LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...
Cochlear Ltd. heard good news from the U.S. FDA, as the agency approved its next-generation cochlear implant, the Nucleus Nexa System, the first smart cochlear implant system. Cochlear expects to ...
Investing.com - Canaccord Genuity upgraded Cochlear Ltd. (ASX:COH) from Hold to Buy and set a price target of AUD330.00, citing strong device demand and promising technology developments. The hearing ...
Cochlear Limited ((AU:COH)) has held its Q4 earnings call. Read on for the main highlights of the call. Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback